Pharmaceutical Executive Digest:
Having trouble viewing this e-mail? Click here.
Share with a colleague
Pharmaceutical Executive Europe  E-News
 
 
 
 
 

You can now follow us on Twitter at Twitter.com/pharmexecutive
 
 
Survey
We asked 40 leaders, Is the pharma supply chain more secure than it was five years ago?
Yes 26%

No

8%
No change 66%
 

Talk to us:
jupton@advanstar.com

Advertise with us:
wblow@advanstar.com

1 July, 2014
Eight Lessons for Enhancing Compliance Effectiveness in Europe
Over and above the challenging compliance landscape in Europe, there is complexity relating to the way companies are organized internally. The key to success in implementing any compliance system will depend on the buy-in of management and staff. Companies that have been successful, write Andy Bender and Geert van Gansewinkel, have focused on the soft side of change...Read more
Focusing on the Marketing Analytics That Matter
No question, data is big on the science side of the pharma business. But things are a little less clear in the marketing department. Peter Houston points to a guide to marketing analytics that offers an interesting DIY approach to focusing in on the metrics that matter ... Read more
Big Pharma’s Tax Exodus: U.S. Treasury Suggests “Something Is Probably Wrong” with the System
It feels like most major U.S. corporations, especially pharmas, are literally running away from their U.S. “tax homes” as fast as they can. But why is this happening now? Has U.S. pharma all of a sudden just decided they have had it with U.S. corporate tax policy? Not exactly, writes Tom Norton ... Read more
Pharm Exec’s Top 50 Pharma Companies
The vigorous return of M&A activity to biopharmaceuticals this year begs the question: is more size and scalable efficiencies the best solution to the declining market power of pharmaceuticals in an endlessly restructuring healthcare system? Our latest annual iteration of the Pharma 50 rankings confirms that the answer to this is ‘no’... Read more
Product Cycle Strategies for Greater Profitability
In this compilation of four in-depth, data-rich reports from Pharmaceutical Executive, you'll learn a new set of metrics allowing companies to align their strategies around the push for greater profitability, putting them on the right track ... Click here to order
Also in this issue
Read the Latest Pharma Exec Global Digest: Transparency Special
Some Content on Content Marketing
FDA Issue Warning Letter to GSK Biologicals
Pharm Exec eBooks Available as Apps